Salesforce (CRM, Financial) has successfully secured a significant partnership with Takeda, as the pharmaceutical giant opts to utilize Salesforce's Life Sciences Cloud for enhancing customer engagement. Through this collaboration, Takeda will integrate Salesforce's Agentforce and Data Cloud technologies to implement customized AI solutions, aimed at improving their medical, commercial, and patient support operations.
This strategic win for Salesforce occurs amidst recent developments where another major pharmaceutical company chose Salesforce for a customized solution, bypassing Vault CRM. Despite Salesforce's gains, KeyBanc highlights that Veeva anticipates retaining the majority of its existing Veeva CRM clients. Additionally, most of the top 20 pharmaceutical firms are expected to make decisions regarding transitioning to Vault CRM over the years 2025 and 2026.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.